Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Association of Exenatide With Liver Enzymes in Patients With Type 2 Diabetes
The Endocrinologist, 06/24/09
Bulchandani D et al. - In patients with type 2 DM, exenatide treatment leads to decrease in AST and ALT independent of weight loss along with a mean reduction of weight and HbA1C.
Related Articles
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 88%
The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 88%
FDA Approves Revisions to Prescribing Information for Diabetes Medications
American Family Physician, 11/06/09
Relevance Score: 87%
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting
Diabetes, Obesity and Metabolism, 10/06/09
Relevance Score: 87%
Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 85%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: A double-blind randomized placebo-controlled trial
Schizophrenia Research, 12/06/09
Comparing effectiveness of risperidone with first-generation antipsychotic medications in patients with schizophrenia-spectrum disorders
Journal of Psychopharmacology, 12/06/09
Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
Schizophrenia Research, 12/06/09
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Laboratory evaluation of thyroid function
The Clinical Advisor, 12/04/09
Familial type 1 diabetes mellitus-gender distribution and age at onset of diabetes distinguish between parent-offspring and sib-pair subgroups
Pediatric Diabetes, 12/04/09
Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit
Pediatric Diabetes, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


